AngioDynamics ANGO has been gaining from its solid prospects with NanoKnife and an increased focus on cancer treatment markets. The optimism, led by a solid second-quarter fiscal 2026 performance, ...

A University of Miami doctor recently removed two cancerous tumors from a patient's liver using only three needle-like probes, a computer and a powerful burst of electricity. His instrument was the ...

There's a special treatment for liver and pancreatic cancers called NanoKnife and it kills cancer cells.The advanced system does not rely on heat. Instead, it uses a more natural method that destroys ...

AngioDynamics has won US Food and Drug Administration (FDA) clearance for its NanoKnife system to be used in prostate cancer patients. The system, which was already FDA-cleared for the surgical ...

Function-Preserving Therapy Recognized in the Medical Devices Category for its Use of Irreversible Electroporation (IRE) Technology in Treatment of Prostate Tumors For the past 25 years, TIME’s Best ...

CEO Jim Clemmer highlighted strong Q3 performance with total revenue reaching $72 million, reflecting over 9% year-over-year growth. MedTech revenue grew by 22%, with continued success across ...

Beaumont Hospitals is now one of 20 hospitals nationwide now offering minimally invasive surgery for soft tissue cancer with the NanoKnife IRE System. Alan Koffron, M.D., surgeon and director, ...

Recently, AngioDynamics ( ANGO) announced that it has won the Investigational Device Exemption (IDE) approval from the U.S. Food and Drug Administration (FDA). The regulatory approval allows this ...

MIAMI — A University of Miami doctor recently removed two cancerous tumors from a patient’s liver using only three needlelike probes, a computer and a powerful burst of electricity. His instrument was ...

Function-Preserving Therapy Recognized in the Medical Devices Category for its Use of Irreversible Electroporation (IRE) Technology in Treatment of Prostate Tumors LATHAM, N.Y.--(BUSINESS ...